Intriguingly, the clinical data from PPISURV40 revealed that GNA13 and BCL2 expressions exhibited opposite prognostic effects on the survival of DLBCL patients (Fig. 3A, B). The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.